TY - JOUR
T1 - An “out of the box” approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes
T2 - combined use of insulin pump and long-acting insulin
AU - Barash, Galia
AU - Lerman, Liat
AU - Ben-Ari, Tal
AU - Abiri, Shirly
AU - Landau, Zohar
AU - Ben Ami, Michal
AU - Brener, Avivit
AU - Lebenthal, Yael
AU - Pinhas-Hamiel, Orit
AU - Mazor-Aronovitch, Kineret
AU - Haim, Alon
AU - Yeshayahu, Yonatan
AU - De Vries, Liat
AU - Rachmiel, Marianna
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Background: Poorly controlled adolescents living with type 1 diabetes (T1D) and pump failure of insulin delivery leading to diabetic ketoacidosis (DKA) are still challenging in the western world. Aim: To investigate the effect of a combination modality of long-acting insulin for basal coverage and a pump for boluses, on the incidence of DKA and glycemic parameters in pediatric and young adults with poorly controlled T1D. Methods: This multicenter, observational retrospective study included 55 patients (age range 3–25 years, 52.7% males) who were treated with the combination modality for a median of 18 months [(IQR)12,47], as part of their clinical care. Data were retrieved at initiation of the combined modality, after 6 months, and at last visit. Results: Cohort’s median age at combination modality initiation was 14.5 years [IQR12.4,17.3], and its median HbA1c level was 9.2% [IQR 8.2,10.2]. The main reasons for combination modality initiation were: (a) concern about sustained hyperglycemia on current management in 41.8%, (b) previous DKA episodes in 30.8%, and (c) refusal to wear a pump continuously in 14.6%. The percent of patients experiencing DKA who used the modality till end decreased from 25.4 to 8.8%. The frequency of DKA events per patient month decreased after 6 months from 0.073 (min 0, max 0.5) to 0.020 (min 0, max 0.5), p = 0.01, and at end to 0.016 (min 0, max 0.25), p = 0.007. Conclusions: The combination modality of once-daily long-acting insulin and pump for boluses is safe, feasible, and effective in preventing DKA among poorly controlled young people living with T1D, unable or un-willing to use advanced closed pumps.
AB - Background: Poorly controlled adolescents living with type 1 diabetes (T1D) and pump failure of insulin delivery leading to diabetic ketoacidosis (DKA) are still challenging in the western world. Aim: To investigate the effect of a combination modality of long-acting insulin for basal coverage and a pump for boluses, on the incidence of DKA and glycemic parameters in pediatric and young adults with poorly controlled T1D. Methods: This multicenter, observational retrospective study included 55 patients (age range 3–25 years, 52.7% males) who were treated with the combination modality for a median of 18 months [(IQR)12,47], as part of their clinical care. Data were retrieved at initiation of the combined modality, after 6 months, and at last visit. Results: Cohort’s median age at combination modality initiation was 14.5 years [IQR12.4,17.3], and its median HbA1c level was 9.2% [IQR 8.2,10.2]. The main reasons for combination modality initiation were: (a) concern about sustained hyperglycemia on current management in 41.8%, (b) previous DKA episodes in 30.8%, and (c) refusal to wear a pump continuously in 14.6%. The percent of patients experiencing DKA who used the modality till end decreased from 25.4 to 8.8%. The frequency of DKA events per patient month decreased after 6 months from 0.073 (min 0, max 0.5) to 0.020 (min 0, max 0.5), p = 0.01, and at end to 0.016 (min 0, max 0.25), p = 0.007. Conclusions: The combination modality of once-daily long-acting insulin and pump for boluses is safe, feasible, and effective in preventing DKA among poorly controlled young people living with T1D, unable or un-willing to use advanced closed pumps.
KW - Adolescents
KW - Diabetic ketoacidosis
KW - Glycemic control
KW - Poorly controlled
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85193336267&partnerID=8YFLogxK
U2 - 10.1007/s00592-024-02264-7
DO - 10.1007/s00592-024-02264-7
M3 - Article
C2 - 38762619
AN - SCOPUS:85193336267
SN - 0940-5429
VL - 61
SP - 1241
EP - 1249
JO - Acta Diabetologica
JF - Acta Diabetologica
IS - 10
ER -